Table 2.
Surgical Outcomes of 11 Pediatric Patients
| No. | EOR | Postoperative Symptom | Complications | Hormone Replacement |
| 1 | TR | Vision normalized | Transient DI | N/A |
| 2 | TR | ACTH normalized, cortisol decreased | Transient DI | Hydrocortisone |
| 3 | STR | Unchanged | N/A | Hydrocortisone |
| 4 | TR | Vision improved, prolactine decreased | N/A | N/A |
| 5 | TR | Vision normalized prolactine decreased | Hypopituitarism transient DI | Thyroxine |
| 6 | TR | Normalized | N/A | N/A |
| 7 | TR | Vision normalized, GH normalized | Hypopituitarism | Thyroxine, hydrocortisone |
| 8 | TR | Vision improved, GH normalized | Transient DI | N/A |
| 9 | STR | Vision improved, GH unchanged | N/A | N/A |
| 10 | TR | GH normalized | N/A | N/A |
| 11 | TR | Vision improved | Hypopituitarism, CSF leak | Thyroxine |
CSF, cerebrospinal fluid; DI, diabetes insipidus; EOR, extent of resection; STR, subtotal resection; TR, total resection.